ECOSTATIN VAGINAL OVULE 150MG DIN 02010267
Health Canada record
| Active ingredient(s) | ECONAZOLE NITRATE 150 MG |
|---|---|
| Dosage form | Suppository |
| Route | Vaginal |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | G01AF05 ECONAZOLE |
| Original market date | 31-Dec-1979 |
| Current status date | 30-May-2007 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bristol-Myers Squibb Canada — licence 100100, currently licensed, last inspection rating C (2026-03-18).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing ECONAZOLE NITRATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02011948 | ECOSTATIN CREAM 1% | BRISTOL-MYERS SQUIBB CANADA | Cream | ECONAZOLE NITRATE 1 % | Cancelled Post Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 5902 | 2004-11-17 | New Drug Submission (NDS) | MANUFACTURER NAME CHANGE |
International API supply for ECONAZOLE NITRATE
2 valid EDQM Certificates of Suitability from 2 holders. 4 active FDA Drug Master Files.
Request a quote for ECOSTATIN VAGINAL OVULE 150MG